// App-Quantinova.ai

TCT CONNECT-249 : Real-World Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

Researchers

Presenter

  • Markus Florian Krackhardt

Principal Investigators

  • Matthias Waliszewski

  • Michel Pansieri

  • Fernando Lozano

  • Tay Mok Heang

  • Martin Hudec

  • Martin Studencan

  • Josepa Mauri

  • Petr Tousek

  • Bruno Garcia

  • Taehoon Ahn

  • Viktor Kocka

  • Bronislav Janek

  • Laurent Sebagh

  • Denny Herberger

  • Gilles Levy

  • Vjekoslav Tomulic

  • Jérôme Rischner

Medical Centers

  • B. Braun Melsungen, Vascular Systems, Berlin, Germany

  • Institut Klinické a Experimentální Medicíny Prague, Prague, Czech Republic

  • Hospital universitario valldhebron, barcelona, Spain

  • ICPC, Paris, France

  • Cardiology Centre of Faculty Hospital, Presov, Slovakia

  • University Hospital Rijeka, Rijeka, Croatia

  • Centre Hospitalier dAvignon, Avignon, France

  • SUSCCH, Banska Bystrica, Slovakia

  • Pantai Ayer Keroh Hospital, Ayer Keroh, Malaysia

  • University General Hospital Ciudad Real, Ciudad Real, Spain

  • Gachon University Gil Medical Center, Incheon, Korea

  • Clinique du Millxenaire, MONTPELLIER, France

  • Charite Universitats Hini Sum, Augustenburger Plate, Germany

  • Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Praha 10, Czech Republic

  • Hospital Albert Schweitzer, Colmar, France

  • Fakultní Nemocnice Královske Vinohrady, Prague, Czech Republic

Locations

  • Germany

  • Malaysia

  • Czech Republic

  • Spain

  • Republic of South Korea

  • France

  • Slovakia

  • Croatia

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Stable coronary artery disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • Clopidogrel bisulfate

  • Ticagrelor

  • Rapacan

Outcome

  • N/A


Study Design

  • Observational

Phase

  • NA

Study Id's

  • NCT02629575

  • NCT02905214

Sponsors

  • N/A

Result

  • Final